Beginning Oct. 1, AstraZeneca will tighten its 340B contract pharmacy restrictions to require claims data on 340B utilization at contract [...] …
Category: Pharma Industry
Exclusive
Arkansas Plans to Challenge J&J’s Contested 340B Rebate Proposal for Violation of State Law
Arkansas plans to challenge Johnson & Johnson’s (J&J’s) 340B rebate proposal for violating the state’s law barring drugmaker contract pharmacy [...] …
A Maryland federal district judge has denied four separate drug industry attempts to block the state’s contract pharmacy access law—marking [...] …
The U.S. government is asking a federal district court in Washington, D.C., to rule for drugmakers in four separate lawsuits [...] …
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...] …
Pharmaceutical manufacturer Merck has announced it will refund 340B covered entities for certain overcharges of its inhaler, Proventil HFA, during [...] …
The new industry vendor administrating Johnson & Johnson’s (J&J’s) contested 340B rebate proposal is hosting an in-person training for third [...] …
German drugmaker Bayer will no longer exempt federal grantees from its 340B contract pharmacy policy beginning Oct. 1—the same day [...] …
Johnson & Johnson (J&J) has ended its contract pharmacy restrictions for covered entities in Arkansas, making the New Jersey-based pharmaceutical [...] …
Certain formulations for four of the first ten drugs selected for Medicare drug price negotiations have newly negotiated prices lower [...] …